Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Erasca, Inc. (ERAS) Balance Sheet

As of 2026-06-30 (10-Q), Erasca, Inc. (ERAS) reported total assets of $435.1M, total liabilities of $73.2M and shareholders' equity of $361.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $42.5M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ERASErasca, Inc.Follow ERAS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
5.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents360.5284.293.167.773.842.5
Short-term investments54.0151.4219.3230.6202.3226.2
Current assets420.0444.5320.7308.8286.2278.4
Total assets501.4514.9395.3502.5396.2435.1
Current liabilities26.248.726.231.428.533.6
Total liabilities44.9103.178.679.071.073.2
Shareholders' equity456.5411.9316.7423.5325.2361.9

USD millions · SEC XBRL

Erasca, Inc. — questions

How much cash does Erasca, Inc. have?
$42.5M in cash and cash equivalents as of 2026-06-30.
What are Erasca, Inc.'s total assets?
$435.1M as of 2026-06-30.
What is Erasca, Inc.'s shareholders' equity?
$361.9M as of 2026-06-30.

Every figure on this page comes from Erasca, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.